• 芒硝外敷对乳腺良性肿块麦默通微创旋切术后疼痛及血肿的影响
  • Effect of the External Application of Mirabilite on Postoperative Pain and Hematoma after the Mammotome Minimally Invasive Resection of Benign Breast Mass
  • 顾燕娜,江起庭.芒硝外敷对乳腺良性肿块麦默通微创旋切术后疼痛及血肿的影响[J].中国烧伤创疡杂志,2019,(1):41~45.
    DOI:
    中文关键词:  芒硝  乳腺良性肿块  麦默通微创旋切术  疼痛  血肿  疗效
    英文关键词:Mirabilite  Benign breast mass  Mammotome minimally invasive resection  Pain  Hematoma
    基金项目:
    作者单位
    顾燕娜 丹阳市人民医院手术室 
    江起庭 南京医科大学附属南京邦德骨科医院手足外科 
    摘要点击次数: 1541
    全文下载次数: 2591
    中文摘要:
          【摘要】 目的 探究芒硝外敷对乳腺良性肿块麦默通微创旋切术后局部疼痛及血肿的影响?方法 按照随机数表法将2017 年7 月至2018 年6 月丹阳市人民医院乳腺外科收治的60 例择期进行麦默通微创旋切术治疗的乳腺良性肿块患者随机分为试验组(30 例) 与对照组(30 例), 其中试验组患者于麦默通微创旋切术后采用3M无菌敷贴+芒硝包+弹力绷带加压包扎术后切口, 对照组患者于麦默通微创旋切术后采用3M无菌敷贴+弹力绷带加压包扎术后切口, 对比观察术后24 及48 h 乳房局部疼痛程度及血肿与感染的发生情况?结果 术后24 h, 试验组患者局部疼痛评分为(2.353±0.141) 分?合并血肿者3 例(回声区范围均为1.0~3.0 cm), 对照组患者局部疼痛评分为(5.251±0.178) 分?合并血肿者12 例(回声区范围均为1.0~3.0 cm); 术后48 h, 试验组患者局部疼痛评分为(1.855±0.162) 分?合并血肿者2 例(回声区范围均为1.0~3.0 cm), 对照组患者局部疼痛评分为(4.823±0.196) 分?合并血肿者10 例(回声区范围均为1.0~3.0 cm)?两组患者术后24 及48 h 局部疼痛评分与血肿发生情况对比, P 均<0.05, 差异具有统计学意义?治疗过程中, 两组患者均未发生感染?结论 芒硝可有效减少乳腺良性肿块麦默通微创旋切术后血肿的发生, 缓解患者的局部疼痛, 且无毒无害?使用时限不受限制?成本较低?操作简便, 值得临床推广应用?
    英文摘要:
          【Abstract】Objective To investigate the effect of external application of Mirabilite on postoperative local pain and hematoma after Mammotome minimally invasive resection of benign breast mass. Methods Sixty patients with benign breast mass, who were admitted into the Breast Surgery of Danyang People’s Hospital for Mammotome minimally invasive resection of benign breast mass from July 2017 to June 2018, were divided, according to the random number table, into an experiment group (30 cases) and a control group (30 cases). After the Mammotome minimally invasive surgery, the incisions of patients in the experiment group were treated with 3M sterile dressing + Mirabilite package + pressure dressing with elastic bandage whereas the incisions in the control group were treated with 3M sterile dressing + pressure dressing with elastic bandage. Local pain and the occurrence of hematoma and infection were observed and compared at 24 h and 48 h after the resection. Results At 24 h after operation, the local pain score was (2.353±0.141) points and 3 cases were complicated with hematoma (echo area ranged from 1.0 to 3.0 cm) in the experiment group, while in the control group, the local pain score was (5.251±0.178) points and hematoma occurred in 12 cases (the echo area ranged from 1.0 to 3.0 cm). At 48 h after operation, the local pain score was (1.855±0.162) points and 2 cases suffered from hematoma (the echo area ranged from 1.0 to 3.0 cm) in the experiment group, while in the control group, the local pain score was (4.823±0.196) points and hematoma was seen in 10 cases (the echo area ranged from 1.0 to 3.0 cm). Local pain scores and the occurrence of hematoma were compared between the two groups respectively at 24 h and 48 h after operation and the results showed statistically significant differences (P < 0.05). During the course of treatment, no infection occurred in either group. Conclusion Mirabilite can effectively reduce the occurrence of hematoma after the Mammotome minimally invasive resection of benign breast mass, reduce patients’ local pain. Moreover, it is toxic-free, harmless, lower-cost and easy to operate, without any limitation to time or place, deserving to be promoted in clinical practice.